Literature DB >> 26644004

Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.

Shumin Lu1, Rong Liu2, Min Su1, Yingze Wei2, Shuyun Yang2, Song He2, Xia Wang3, Fulin Qiang2, Chen Chen1, Shuyang Zhao1, Weiwei Zhang1, Pan Xu1, Guoxin Mao4.   

Abstract

This study focused on determining the role of Spy1 in human epithelial ovarian cancer (EOC). Speedy is a novel cell cycle protein capable of promoting cell proliferation. In this study, western blot and immunohistochemistrical analyses were performed to detect the expression of Spy1 in ovarian cancer. Spy1 protein levels increased with ovarian cancer grade, and Kaplan-Meier curve showed that overexpression of Spy1 was significantly correlated with reduced patient survival. In vitro, Spy1 depletion in ovarian cell lines led to reduced proliferation according to CCK8 and plate colony assays. The expression of Spy1 was positively related to pThr187-p27. Flow cytometry revealed that the reduced expression of Spy1 induced the apoptosis of the EOC cells. In summary, our findings suggested that Spy1 may be a novel independent prognostic predictor of survival for ovarian patients.

Entities:  

Keywords:  Apoptosis; Ovarian cancer; Proliferation; Spy1

Mesh:

Substances:

Year:  2015        PMID: 26644004     DOI: 10.1007/s10735-015-9646-z

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  37 in total

1.  Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.

Authors:  Christopher W McAndrew; Randy F Gastwirt; April N Meyer; Lisa A Porter; Daniel J Donoghue
Journal:  Cell Cycle       Date:  2007-05-30       Impact factor: 4.534

2.  The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

Authors:  Azadeh Golipour; Dorothy Myers; Tiffany Seagroves; Daniel Murphy; Gerard I Evan; Daniel J Donoghue; Roger A Moorehead; Lisa A Porter
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 3.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

4.  Spy1 is frequently overexpressed in malignant gliomas and critically regulates the proliferation of glioma cells.

Authors:  Li Zhang; Aiguo Shen; Qing Ke; Wei Zhao; Meijuan Yan; Chun Cheng
Journal:  J Mol Neurosci       Date:  2012-03-25       Impact factor: 3.444

Review 5.  p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

Authors:  B Belletti; M S Nicoloso; M Schiappacassi; E Chimienti; S Berton; F Lovat; A Colombatti; G Baldassarre
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

6.  The prognostic of p27(kip1) in ovarian cancer: a meta-analysis.

Authors:  Mudan Lu; You Wang; Fei Xu; Jingying Xiang; Daozhen Chen
Journal:  Arch Gynecol Obstet       Date:  2015-07-22       Impact factor: 2.344

Review 7.  Risk assessment and genetic testing for ovarian cancer.

Authors:  Cassandra Gulden; Olufunmilayo I Olopade
Journal:  AJR Am J Roentgenol       Date:  2010-02       Impact factor: 3.959

8.  The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables.

Authors:  Gulay Turan; Ceyda Sancakli Usta; Akin Usta; Mehmet Kanter; Lema Tavli; Meric Karacan; Cetin Celik; Metin Eser
Journal:  J Mol Histol       Date:  2014-08-09       Impact factor: 2.611

9.  Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.

Authors:  Yuchan Wang; Fang Liu; Feng Mao; Qinlei Hang; Xiaodong Huang; Song He; Yingying Wang; Chun Cheng; Huijie Wang; Guangfei Xu; Tianyi Zhang; Aiguo Shen
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

10.  Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.

Authors:  Min Fei; Qinglei Hang; Sicong Hou; Changgeng Ruan
Journal:  Int J Hematol       Date:  2013-09-14       Impact factor: 2.490

View more
  3 in total

1.  Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

Authors:  Denise A McGrath; Bre-Anne Fifield; Aimee H Marceau; Sarvind Tripathi; Lisa A Porter; Seth M Rubin
Journal:  EMBO J       Date:  2017-06-30       Impact factor: 11.598

2.  Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments.

Authors:  Rosa-Maria Ferraiuolo; Bre-Anne Fifield; Caroline Hamm; Lisa A Porter
Journal:  Breast Cancer Res Treat       Date:  2022-08-27       Impact factor: 4.624

3.  High Spy1 expression predicts poor prognosis in colorectal cancer.

Authors:  Qin Jin; Gang Liu; Luri Bao; Yuzhen Ma; Huidong Qi; Zhizhong Yun; Yanfeng Dai; Shu Zhang
Journal:  Cancer Manag Res       Date:  2018-08-16       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.